These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16901577)

  • 1. Endpoints for clinical trials on treatment of hepatitis C.
    Kang H; Lok AS
    J Hepatol; 2006 Oct; 45(4):473-5. PubMed ID: 16901577
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C. Development of new drugs and clinical trials: promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003.
    Pawlotsky JM; McHutchison JG
    Hepatology; 2004 Feb; 39(2):554-67. PubMed ID: 14768012
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.
    Tang J; Kaslow RA
    Pharmacogenomics J; 2004; 4(3):171-4. PubMed ID: 15069460
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel hepatitis C drugs in current trials.
    Kronenberger B; Welsch C; Forestier N; Zeuzem S
    Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions in therapy for chronic hepatitis C.
    Jensen DM; Ascione A
    Antivir Ther; 2008; 13 Suppl 1():31-6. PubMed ID: 18432161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues in designing and interpreting clinical trials of treatments for chronic hepatitis C.
    O'Brien C
    J Viral Hepat; 2006 May; 13 Suppl 1():6-14. PubMed ID: 16630042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study Results Support Telaprevir-Based Therapy for HCV.
    AIDS Patient Care STDS; 2010 Nov; 24(11):746. PubMed ID: 21108519
    [No Abstract]   [Full Text] [Related]  

  • 9. New HCV drugs trigger race for more tolerable therapies.
    Williams SC
    Nat Med; 2011 Dec; 17(12):1526. PubMed ID: 22146431
    [No Abstract]   [Full Text] [Related]  

  • 10. Ribavirin in chronic hepatitis C: past and future.
    Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
    [No Abstract]   [Full Text] [Related]  

  • 11. Future treatment of chronic hepatitis C.
    Keeffe EB
    Antivir Ther; 2007; 12(7):1015-25. PubMed ID: 18018759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine protease inhibitors as anti-hepatitis C virus agents.
    Reiser M; Timm J
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial watch: Protease inhibitors show promise against HCV.
    Nat Rev Drug Discov; 2009 Jan; 8(1):11. PubMed ID: 19116621
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis C and B (HCV, HBV)].
    Violante MD
    Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():101-3. PubMed ID: 17037789
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatitis C is curable. Even slightly elevated liver enzymes need further examination].
    Niederau C
    MMW Fortschr Med; 2008 Mar; 150(13):26. PubMed ID: 18522352
    [No Abstract]   [Full Text] [Related]  

  • 16. Cause-effect relationship between the hepatitis C virus and insulin resistance at the time of direct antiviral therapy.
    Negro F
    Gut; 2010 Dec; 59(12):1590-1. PubMed ID: 20926646
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of patients infected with chronic hepatitis C genotype 2 and 3: more data, more questions?
    Graziadei IW; Vogel W
    Hepatology; 2009 Feb; 49(2):345-7. PubMed ID: 19177579
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-acting antiviral agents for the treatment of HCV.
    Thompson AJ; Locarnini S
    Antivir Ther; 2012; 17(6 Pt B):1105-7. PubMed ID: 23188736
    [No Abstract]   [Full Text] [Related]  

  • 20. The gap between registration trials and real world in hepatitis C is closing.
    Berden FA; Vuik FE; Drenth JP; Kievit W
    Dig Liver Dis; 2017 Apr; 49(4):454-455. PubMed ID: 28190697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.